Argus Upgrades Teva Pharma (TEVA) to Buy
Tweet
Share
E-mailGet Alerts TEVA Hot Sheet
Price: $36.48 --0%
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 15 | New: 6
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 15 | New: 6
Join SI Premium – FREE
Argus upgraded Teva Pharma (NYSE: TEVA) from Hold to Buy with a price target of $58.00.
For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.
Shares of Teva Pharma closed at $50.95 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Argus Upgrades Centene (CNC) to Buy
- Northcoast Downgrades MarineMax (HZO) to Neutral
- Greenland Mines begins drilling at Skaergaard PGM deposit
Create E-mail Alert Related Categories
UpgradesRelated Entities
ArgusSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
